Analgesics in New Zealand delivers robust value gains in 2026 despite limited growth in unit sales, outperforming regional benchmarks where mature demand and cautious consumer spending have slowed expansion. This environment remains attractive for brands that can innovate, as value growth is concentrated among premium, differentiated solutions while everyday pain management continues to shift toward generics and value formats. Strategic success increasingly hinges on adapting to empowered self-care, as digital health tools and AI-driven recommendations shape purchase choices and reinforce the need for transparent, safety-focused communication, with pharmacy and grocery channels evolving in response to these new consumer pathways. With systemic analgesics maintaining the largest share but topical and anaesthetic formats accelerating ahead, the competitive landscape favours brands able to combine trusted efficacy, tailored product claims, and digital engagement to capture both cost-conscious and quality-driven shoppers.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in New Zealand with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in New Zealand, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in New Zealand report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in New Zealand?
- Which are the leading brands in Analgesics in New Zealand?
- How are products distributed in Analgesics in New Zealand?
- How has the regulatory and operating environment for Analgesics changed in New Zealand?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Consumers shift to premium solutions as cost pressures rise
AI-powered tools and digital content drive confident self-medication
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Digital-savvy shoppers to drive demand for differentiated pain relief
Self-management and retail channel shifts to reshape purchasing decisions
Innovation and regulatory vigilance will define the path to value growth
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Haleon strengthens leadership as Voltaren and Panadol drive trust and growth
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Supermarkets expand lead as pain relief shifts from pharmacy
Online channels gain traction as younger shoppers embrace convenience
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!